First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study

MLA

Godelieve, Meunier, et al. “First-Line Therapy for Chronic Lymphocytic Leukemia in Patients Older than 79 Years Is Feasible and Achieves Good Results: A FILO Retrospective Study.” Hematological Oncology, vol. 35, no. 4, Aug. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........02480eb665a74c6feef75698572d5371&authtype=sso&custid=ns315887.

APA

Godelieve, M., Loic, Y., Phi Linh, N.-T., Stéphane, L., Anne, Q., Jehan, D., Richard, L., Thérèse, A., Cécile, T., Florence, C., Marie Sarah, D., Annie, B., Pierre, M., Bruno, C., Véronique, L., Guillaume, C., Daniel, R., Marie Christine, B., Anne Sophie, M., & Pierre, F. (2016). First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study. Hematological Oncology, 35(4).

Chicago

Godelieve, Meunier, Ysebaert Loic, Nguyen-Thi Phi Linh, Lepretre Stéphane, Quinquenel Anne, Dupuis Jehan, Lemal Richard, et al. 2016. “First-Line Therapy for Chronic Lymphocytic Leukemia in Patients Older than 79 Years Is Feasible and Achieves Good Results: A FILO Retrospective Study.” Hematological Oncology 35 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........02480eb665a74c6feef75698572d5371&authtype=sso&custid=ns315887.